Status:

COMPLETED

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Lead Sponsor:

Austrian Breast & Colorectal Cancer Study Group

Collaborating Sponsors:

AstraZeneca

Conditions:

Early-stage Breast Cancer

Eligibility:

FEMALE

50-80 years

Phase:

PHASE3

Brief Summary

Primarily, this clinical investigation compared the efficacy of tamoxifen + aminoglutethimide vs. tamoxifen alone in terms of prognosis (overall survival) in postmenopausal patients with potentially c...

Eligibility Criteria

Inclusion

  • Postmenopausal patients with histologically verified, locoradically treated, invasive or minimally invasive breast cancer
  • Hormone receptor-positive status
  • More than 6 histologically examined lymph nodes
  • Laboratory parameters
  • hematopoiesis: \> 3500/µl leucocytes, \> 100,000/µl thrombocytes
  • renal function: creatinin \< 1.5mg%
  • hepatic function: GOT \< 2.5 x UNL
  • bilirubin: \< 1.5mg %
  • metabolic parameters: Na, Ca, K in normal range, normal level of blood sugar
  • Concluded healing process following surgery
  • Less than 4 weeks interval since surgery
  • Informed consent

Exclusion

  • Premenopausal patients, non-determinable menopausal status
  • Previous radiotherapy, chemotherapy or endocrine treatment
  • Generalized disease (as verified by lung X-ray, skeletal X-ray, liver ultrasound)
  • Contraindications against tamoxifen or anastrozole
  • T4 tumors; carcinoma in situ
  • Lacking compliance or understanding of disease
  • Karnofsky Index \< 3
  • Serious concomitant disease
  • Septic complications, systemic infections or infectious local processes
  • Bilateral ovariectomy or ovarian irradiation
  • Second carcinoma or status post second carcinoma (except for treated squamous cell carcinoma of the skin or cervical carcinoma in situ)

Key Trial Info

Start Date :

December 1 1990

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2000

Estimated Enrollment :

2021 Patients enrolled

Trial Details

Trial ID

NCT00309491

Start Date

December 1 1990

End Date

March 1 2000

Last Update

October 19 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.